Brief: Anebulo Pharmaceuticals Announces Issuance Of U.S. Patent Covering Use Of Aneb-001 For The Treatment Of Acute Cannabinoid Overdose
13/10/2021 13:47
Oct 13 (Reuters) - Anebulo Pharmaceuticals Inc ANEB.O :
* ANEBULO PHARMACEUTICALS ANNOUNCES ISSUANCE OF U.S. PATENT
COVERING USE OF ANEB-001 FOR THE TREATMENT OF ACUTE CANNABINOID
OVERDOSE
Source text for Eikon: ID:nBw7cNWZka
Further company coverage: ANEB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anebulo Pharmaceuticals
See all newsAdvisory: Dated alert on Anebulo Pharmaceuticals' voluntary delisting from Nasdaq withdrawn
Anebulo Pharmaceuticals Q2 net loss narrows
Brief: Anebulo Pharmaceuticals Announces Intention To Voluntarily Delist From Nasdaq And Deregister With SEC
Anebulo Pharmaceuticals posts Q1 net loss
Brief: Anebulo Pharmaceuticals Reports Fourth Quarter And Fiscal Year 2025 Financial Results